Results 101 to 110 of about 5,935 (185)

Response to letter: "The effect of P2Y12 receptor inhibitors on clinical outcomes in patients with acute coronary syndrome undergoing PCI and receiving abciximab". [PDF]

Cardiol J
Altınkaya O, Aydemir S, Özkoç M.
europepmc   +1 more source

One year outcomes with abciximab vs. placebo during percutaneous coronary intervention after pre-treatment with clopidogrel

, 2008
Das 30-Tage-Ergebnis der ISAR-REACT-Studie erbrachte keinen klinischen Vorteil durch Abciximab bei Patienten mit perkutaner Koronarimplantation und einer Gabe von 600mg Clopidogrel mindestens zwei Stunden vor dem Eingriff.
Drescher, Andrea
core  

Response to the response to the letter: "The effect of P2Y12 receptor inhibitors on clinical outcomes in patients with acute coronary syndrome undergoing PCI and receiving abciximab". [PDF]

Cardiol J
Umińska JM.
europepmc   +1 more source

A Paradoxical Role of ADAMTS13: Enhancing Collagen-Induced Platelet Aggregation and Activation via AKT Phosphorylation. [PDF]

Thromb Haemost
Dong H, Mao Y, Zheng XL.
europepmc   +1 more source

Intracoronary adjunctive therapies for ST-elevation myocardial infarction: a network meta-analysis of trials. [PDF]

Eur Heart J Cardiovasc Pharmacother
Laborante R, Bianchini E, Ciliberti G, Paglianiti DA, Filomia S, Bianchini F, Galli M, Biondi-Zoccai G, Serruys PW, Crea F, Patti G, Savarese G, Trani C, Burzotta F, D'Amario D.   +14 more
europepmc   +1 more source

Thrombo-inflammation and Rethinking the Role of Aspirin in Kawasaki Disease. [PDF]

Curr Rheumatol Rep
Kocatürk B, Berberoğulları B, Aliyev E, Sağ E, Özen S, Arditi M.   +5 more
europepmc   +1 more source

Cost Effectiveness of Abciximab During Routine Medical Practice

Objective: To estimate the cost per ischaemic event (death, nonfatal myocardial infarction, subsequent revascularisation procedure) avoided at 6 months in high risk patients undergoing coronary revascularisation treated with abciximab during routine ...
C. Daniel Mullins, Shelby Ogilvie Reed, Laurence S. Magder   +2 more
core  

Letter to the Editor regarding: "The effect of P2Y12 receptor inhibitors on clinical outcomes in patients with acute coronary syndrome undergoing PCI". [PDF]

Cardiol J
Umińska JM.
europepmc   +1 more source

Modeling Versus Balancing Approaches to Addressing Instrumental Variables in Weighting: A Comparison of the Outcome-Adaptive Lasso, Stable Balancing Weighting, and Stable Confounder Selection. [PDF]

Pharmacoepidemiol Drug Saf
Choi BY, Brookhart MA.
europepmc   +1 more source

Trombocitopenia extrema secundaria a abciximab

, 2004
Los antiagregantes antiglucoproteína IIb/IIIa bloquean la unión del fibrinógeno y el factor de Von Willebrand a sus receptores. Pueden causar hemorragia y trombocitopenia.
Delgado Amaya, Manuel, Prieto Palomino, Miguel A., Aragonés Manzanares, R., Bullones Ramírez, Juan A., Arias García, Dolores M., Castillo Castro, José L.   +5 more
core